Strong Media Interest in Neuspera

07.29.24

Neuspera Medical is very excited and grateful for the tremendous interest in our progress towards reinventing sacral neuromodulation for treating OAB. The Neuspera Sacral Neuromodulation System includes innovations designed to significantly impact patient acceptance and satisfaction with this potentially life-changing therapy in a large market that has been largely underserved to date. Our two recent press releases were published by more than 1,000 news outlets around the world! Thank you for helping us spread the word that Neuspera Sacral Neuromodulation is coming! The following is a select sample of the many media outlets that have covered our news in the past two weeks.

Fortune

AdvaMed

AlleyWatch

Urology Times

MassDevice

WSJ

Forbes

Clinical Trials Arena

VC News Daily